Small populations, big impact: leveraging rare disease gene therapies to benefit millions

• Text
• PDF

Abstract

Authors

Stephanie Cherqui

The Lasker-Bloomberg Public Service Award honors Michael J. Fox’s advocacy for Parkinson’s disease patients and research

• Text
• PDF

Abstract

Authors

Dimitri Krainc

Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy

• Text
• PDF

Abstract

Authors

Clifford B. Saper

Kunihiro Hattori, Tomoyuki Igawa, and Takehisa Kitazawa share Lasker Award honors for revolutionary hemophilia A therapy

• Text
• PDF

Abstract

Authors

Robert Flaumenhaft

GLP-1–targeted therapies for alcohol and other substance use disorders: a new era on the horizon?

• Text
• PDF

Abstract

Authors

Lorenzo Leggio, W. Kyle Simmons

Do the math: modernizing the FDA’s evidence paradigm for precision medicine

• Text
• PDF

Abstract

Authors

Peter J. Pitts, Judea Pearl, Arthur L. Caplan, Robert Goldberg

The Parkinson’s pandemic: prioritizing environmental policy and biological resilience via the gut

• Text
• PDF

Abstract

Authors

Bianca Palushaj, Robin M. Voigt

The hidden world of nanoplastics colliding with neurodegenerative diseases

• Text
• PDF

Abstract

Authors

Andrew B. West, Matthew J. Campen, Mark Wiesner, Jason A. Somarelli, Jason W. Arnold

The carcinogenic consequences of the plastic pollution crisis

• Text
• PDF

Abstract

Authors

Jason A. Somarelli, Jason W. Arnold, Andrew B. West

Isn’t it ironic? Functional iron deficiency at the core of Parkinson’s disease pathobiology

• Text
• PDF

Abstract

Authors

Ian Peikon, Nancy C. Andrews